Why is Bajaj Healthcare Ltd falling/rising?

Short-Term Price Movement and Market Activity

On the day in question, Bajaj Healthcare outperformed its sector by 6.23%, marking a significant gain relative to peers. The stock opened with a gap up of 7.78%, signalling strong buying interest early in the session. It also reached an intraday high of ₹369.20, maintaining upward momentum throughout the day. This price action follows two consecutive days of gains, during which the stock appreciated by 8.47%, indicating a short-term bullish trend.

However, despite this price strength, investor participation showed signs of moderation. Delivery volume on 28 Jan was recorded at 60,780 shares, representing an 11.96% decline compared to the five-day average delivery volume. This suggests that while the stock price rose, the intensity of investor commitment was somewhat subdued. Additionally, the weighted average price indicated that more volume traded near the lower end of the day’s price range, hinting at some selling pressure at higher levels.

Fundamental Performance Driving Recent Gains

The recent price rise is underpinned by a series of encouraging fundamental developments. Bajaj Healthcare has reported positive results for three consecutive quarters, with its profit after tax (PAT) for the nine-month period reaching ₹42.41 crores, reflecting a robust growth rate of 22.82%. The company’s operating profit to interest coverage ratio has also improved, reaching a quarterly high of 5.22 times, which indicates enhanced ability to service interest expenses.

Net sales for the quarter hit a record ₹161.22 crores, further supporting the company’s improving operational performance. These results have likely contributed to renewed investor confidence, driving the recent uptick in the stock price.

Valuation and Long-Term Challenges

Despite the recent positive momentum, Bajaj Healthcare’s long-term performance remains a concern. Over the past year, the stock has delivered a negative return of 44.60%, significantly underperforming the Sensex, which gained 7.88% during the same period. The stock has also lagged behind the broader BSE500 index over one, three, and five-year horizons.

Operating profit growth has been weak, with a compound annual growth rate (CAGR) of -9.00% over the last five years. Furthermore, the company’s debt servicing capacity is limited, as evidenced by a high Debt to EBITDA ratio of 2.59 times. This elevated leverage poses risks to financial stability and investor sentiment.

Nonetheless, the company’s return on capital employed (ROCE) stands at a moderate 8.1%, and it trades at an attractive valuation with an enterprise value to capital employed ratio of 1.9. The stock is currently priced at a discount relative to its peers’ historical averages, which may appeal to value-oriented investors. Additionally, the company’s profits have grown by 18.4% over the past year, resulting in a price-to-earnings-growth (PEG) ratio of 1.2, suggesting a reasonable valuation given earnings growth.

Investor Outlook and Conclusion

In summary, Bajaj Healthcare’s recent price rise on 29-Jan reflects a short-term rebound fuelled by strong quarterly results and improved profitability metrics. The stock’s outperformance relative to its sector and the gap-up opening indicate renewed investor interest. However, the broader context of weak long-term fundamentals, high leverage, and sustained underperformance against benchmarks tempers enthusiasm.

Investors should weigh the company’s improving operational performance and attractive valuation against its historical challenges and debt concerns. While the stock’s recent gains may offer a tactical opportunity, caution is warranted given the mixed signals from its financial health and market performance.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →